Lipospheres for Simultaneous Controlled Release and Improved Pharmacokinetic Profiles of Saxagliptin-Enalapril: Formulation, Optimization, and Comparative In Vitro-In Vivo Evaluation
Authors (first, second and last of 4)
AAPS PharmSciTech, an official journal of the American Association of Pharmaceutical Scientists, publishes papers that focus on the research, development, and evaluation of pharmaceutical dosage forms and delivery systems. Innovative in its content and practices, AAPS PharmSciTech, an online-only journal, uses technologically-driven tools and methods by which the scientific community can more efficiently disseminate their research.
- Announcement to all AAPS members:
- To provide a more enhanced and user-friendly experience, AAPS members of the AAPS society can now easily access all of the journal’s content by signing in directly to AAPS (www.aaps.org/MemberJournals). To prevent any confusion and to ease the transition, attempts to access PharmaGateway will be redirected to the AAPS login webpage, starting July 1, 2016.
Journal information
- Main Editor
-
- Robert O. Williams
- Publishing model
- Hybrid. Open Access options available
Journal metrics
- 2.401 (2019)
- Impact factor
- 2.703 (2019)
- Five year impact factor
- 368,743 (2019)
- Downloads
Latest issue
Latest articles
-
-
Impact of Drug-Polymer Interaction in Amorphous Solid Dispersion Aiming for the Supersaturation of Poorly Soluble Drug in Biorelevant Medium
Authors (first, second and last of 7)
-
Enhanced Oral Delivery of Curcumin via Vitamin E TPGS Modified Nanodiamonds: a Comparative Study on the Efficacy of Non-covalent and Covalent Conjugated Strategies
Authors (first, second and last of 8)
-
Employing Multivariate Statistics and Latent Variable Models to Identify and Quantify Complex Relationships in Typical Compression Studies
Authors (first, second and last of 4)
-
(−)-linalool-Loaded Polymeric Nanocapsules Are a Potential Candidate to Fibromyalgia Treatment
Authors (first, second and last of 14)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Featured Article
We invite you to read a selected article from the April 2019 issue of the journal:
Delivery Technologies for Orally Inhaled Products: an Update.
Societies, partners and affiliations
About this journal
- Electronic ISSN
- 1530-9932
- Co-Publisher information
- American Association of Pharmaceutical Scientists
- Abstracted and indexed in
-
- CNKI
- Chemical Abstracts Service (CAS)
- Dimensions
- EBSCO Discovery Service
- EMBASE
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- UGC-CARE List (India)
- Copyright information
